Chan Zuckerberg Initiative

FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS

Retrieved on: 
Thursday, September 15, 2022
Hospital, Incidence, Awareness, Woman, Inflammation, The Tavis Smiley Show, Mallinckrodt, FDA, Argument from ignorance, Social media, News, White Americans, USA Today, Patient, Clinical trial, White, ACTE, FSR, Chan Zuckerberg Initiative, Yahoo!, Goal, Foundation, Caregiver, Black, Research, Boehringer Ingelheim, Man, African Americans, Education, Equity, Pharmaceutical industry, Sarcoidosis

CHICAGO, Sept. 15, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of the Ignore No More: ACTe Now! (Advance Clinical Trials for Equity in Sarcoidosis) campaign. The goals of this campaign are to increase representation of Black American sarcoidosis patients in clinical trials, raise awareness of disparities that exist in sarcoidosis, identify the challenges and barriers that contribute to lower participation by Black Americans in clinical trials, and to provide recommendations that foster a more inclusive approach to recruiting patients for clinical trials and research.  

Key Points: 
  • Black Americans are 2.5 times more likely to have sarcoidosis and are 12 times more likely to die from sarcoidosis than White Americans.
  • While Black Americans are disproportionately impacted by chronic illnesses and diseases across the spectrum, they are significantly underrepresented in clinical trials and research.
  • "It is imperative to increase representation of Black Americans in clinical trials and research efforts in order to close the gap in care and improve patient outcomes for Black Americans with sarcoidosis," said Mary McGowan, Chief Executive Officer for FSR.
  • The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and to improving care for sarcoidosis patients through research, education, and support.

Dense Liquid Droplets Act as Cellular Computers

Retrieved on: 
Wednesday, September 14, 2022
Institute, NMR, Enzyme, American Cancer Society, Ribosome, MAPK3, Crowding, Acceleration, AT8, Department, DAAD, National, Neurodegeneration, NYU Langone Health, Q-system (genetics), Cyclin-dependent kinase 1, Neoplasm, TR01, Computer, European Research Council, Chan Zuckerberg Initiative, The German, Structural biology, National Institutes of Health, Max Planck Society, Biochemistry, MTORC1, Patient, Defense, Genetics, Protein, Cell, German Center for Neurodegenerative Diseases, NYU, Doctor of Philosophy, Research, Water, Kinase, DZNE, New York University Grossman School of Medicine, Alzheimer's disease, Phosphorylation, Phosphorus, Medical imaging, Pharmaceutical industry, Fine chemical, Molecular Cell

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- An emerging field explores how groups of molecules condense together inside cells, the way oil droplets assemble and separate from water in a vinaigrette.

Key Points: 
  • In human cells, "liquid-liquid phase separation" occurs because similar, large molecules glom together into dense droplets separated from the more diluted parts of the fluid cell interior.
  • Researchers compare condensates to microprocessors, computers built into circuits, because both recognize and calculate responses based on incoming information.
  • Kinases are protein switches that influence cellular processes by phosphorylating attaching a molecule called a phosphate group to target molecules.
  • Finally, the researchers also hope that their findings advance the design of other cellular computers that react to physical forces.

EMURGO Ventures Invests in AID:Tech to Advance Web3 Solutions for Onchain Reputation & Rewards

Retrieved on: 
Thursday, August 25, 2022
COO, University, Chan Zuckerberg Initiative, Tech, Time, Solution, Volunteering, DIDS, Non-fungible token, Organization, NFT, Organic, Interview, Blockchain, Ecosystem, Champions League, Non-governmental organization, Adoption, Cryptocurrency, Cardano

AID:Tech is building On-chain Reputation & Rewards for Web3 with a focus on real-world use cases.

Key Points: 
  • AID:Tech is building On-chain Reputation & Rewards for Web3 with a focus on real-world use cases.
  • AID:Tech enables people to build a reputation score, which is linked to their on-chain reputation.
  • "EMURGO Ventures is excited to further support AID:Tech's endeavors to build more socially impactful Web3 solutions for charitable causes that also align with Cardano's Web3 expansion."
  • Ltd. ("EMURGO") and invests in a variety of startups and middleware solutions companies to drive Cardano's Web3 adoption.

Daniel Danker Joins Andela Board of Directors

Retrieved on: 
Monday, August 22, 2022
Product, Instacart, ViacomCBS, Daniel, CEO, Technology, HackerOne, View, Uber Eats, List of Facebook features, SoftBank Group, Chief technology officer, GitHub, Music, Generation Investment Management, Global Partnership for Education, Goldman Sachs, Citrix Systems, Roku, Spark Capital, Multimedia, Restaurant, Chan Zuckerberg Initiative, News, Algorithm, Education, Facebook, Facebook Watch, GV (company), Knowledge, Growth, General partnership, Management, Food delivery, Video game, Online shopping, Shazam, Engineering, Cloudflare

NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Andela , the global marketplace for remote technical talent, announced today the appointment of Daniel Danker to the board of directors, effective 9th August 2022.

Key Points: 
  • NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Andela , the global marketplace for remote technical talent, announced today the appointment of Daniel Danker to the board of directors, effective 9th August 2022.
  • Daniel Danker, Chief Product Officer, Instacart joins board of directors for Andela, the remote tech talent marketplace.
  • An experienced executive with a proven track record of driving product success, Daniel currently oversees product strategy, direction and consumer experience for Instacart.
  • A distributed organization spanning six continents, Andela is backed by investors including Generation Investment Management, Chan Zuckerberg Initiative, Spark Capital, and Google Ventures.

UNITED HOPE BUILDERS AND INDIEDWELL BREAK GROUND ON NEW AFFORDABLE HOUSING FACTORY IN EAST PALO ALTO, WITH 100 GOOD JOBS, BRINGING THE PROMISE OF MORE AFFORDABLE HOUSING IN THE BAY AREA

Retrieved on: 
Thursday, July 28, 2022
Silicon, Professional corporation, David and Lucile Packard Foundation, Palo Alto, California, Foundation, New York state public-benefit corporations, Watts Labor Community Action Committee, Partnership, Ownership, News, County, Romic alphabet, Bay Road (Bristol County, Massachusetts), PALO, Bains, Chan Zuckerberg Initiative, David and Lucile Packard Foundation Headquarters, Housing, Silicon Valley Community Foundation, San Francisco Bay, BIPOC, City, Warehouse, Renewable energy, San Francisco Bay Area, UHB

"This is an important milestone in our efforts to bring more affordable housing to the Bay Area," Pastor Bains said.

Key Points: 
  • "This is an important milestone in our efforts to bring more affordable housing to the Bay Area," Pastor Bains said.
  • This joint venture factory with indieDwell which is mission and values-aligned with our organization will put faster-to-build, less expensive housing products into the hands of affordable housing developers.
  • Coupled with UHB's political network and growing project development team, we plan to move the needle for affordable housing in the Bay Area."
  • The Bay Area and our unhoused residents need solutions like United Hope Builders and indieDwell."

CELL BY CELL, SCIENTISTS ARE BUILDING A HIGH-RESOLUTION MAP OF BRAIN CHANGES IN ALZHEIMER'S DISEASE

Retrieved on: 
Thursday, July 28, 2022
ACT, National, NIH, University of Washington School of Medicine, Microscopy, Gene, Cell, Allen Institute, Ageing, Method, Chromatin, Professor, Hope, MTG, Death, National Institute on Aging, Brain, Education, Learning, Research, B cell, HIV disease progression rates, Memory, Adult, Jayadev, Nintendo Integrated Research & Development, RNA, Pathology, Medicine, Government, Entorhinal cortex, Allen Institute for Brain Science, Health, BRAIN Initiative, Muscle atrophy, Conference, Organization, Disease, Science, Neuron, University, Neuropathology, University of California, Santa Cruz, Sex, Gaps, Neurodegeneration, Dementia, Microglia, National Institute, Chan Zuckerberg Initiative, Genome browser, Language, Senior, Patient, Medical imaging, Mobile phone, Vaccine, Pharmaceutical industry, Alzheimer's disease

SEATTLE, July 28, 2022 /PRNewswire/ -- Alzheimer's disease wreaks unmistakable havoc in the brain.

Key Points: 
  • Nobody knows what triggers these huge brain changes in Alzheimer's disease, let alone how to stop or reverse them.
  • Scientists still don't understand the biological changes that trigger Alzheimer's disease, which afflicts more than 6 million Americans and is the most common cause of dementia.
  • Understanding the true cellular roots of the disease will take more data, from more parts of the brain.
  • The scientists compared these cell types to those from younger, healthy brain donors a cell-type reference map generated earlier by the Allen Institute team and their collaborators through the NIH-funded BRAIN Initiative Cell Census Network.

Twelve to Deploy World’s First Industrial-Scale Carbon Transformation Platform    

Retrieved on: 
Wednesday, June 29, 2022
Automotive, Air, Other Energy, Transport, Other Automotive, General Automotive, Oil, Gas, Alternative Vehicles, Fuels, Environment, Energy, Sustainability, Carbon, Independent Board for Presbyterian Foreign Missions, Procter & Gamble, CEO, CZI, Electronics, Research, Engineering, Climate change, Pioneer, Mercedes-Benz, Atmosphere, SAF, CO2, United, Fast Company, NASA, Technology, Organization, Chan Zuckerberg Initiative, Policy, Chemistry, Multimedia, Renewable energy, Jet fuel, Linde, Shopify, Sustainability

View the full release here: https://www.businesswire.com/news/home/20220629005271/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220629005271/en/
    Twelves carbon transformation technology converts captured CO2 into products historically made from fossil fuels.
  • Delivering low-carbon sustainable products consumers desire will require scaling innovative solutions such as Twelves carbon transformation technology.
  • Carbon transformation has the potential to turn CO2 from a harmful waste stream into useful products for the global economy, said Jonathan Goldberg, CEO of Carbon Direct.
  • We call it carbon transformation, and it fundamentally changes how we can address climate change, reduce emissions and reverse the carbon imbalance.

Foundation for Sarcoidosis Research Launches Groundbreaking Global Rare Disease Initiative

Retrieved on: 
Tuesday, June 21, 2022
University of Mississippi Medical Center, University of Florida College of Medicine-Jacksonville, Medical school, University of Virginia, Stanford University School of Medicine, Man, Hospital, University, Health, Quality of life, Incidence, Royal Oak, Jane, Interview, Florida College, UCLA, Thomas Jefferson University, Alliance, Mount Sinai Medical Center, Program, Emory Healthcare, Education, Chan Zuckerberg Initiative, Beaumont Health, National Jewish Health, UT Health East Texas - North Campus, Patient, Medical University of South Carolina, Multimedia, Rare, McGowan, Woman, FSR, STAR, VCU, Research, Foundation, Inflammation, Inova Health System, Center of excellence, Pharmaceutical industry, Medicine, Sarcoidosis

CHICAGO, June 21, 2022 /PRNewswire/ -- Foundation for Sarcoidosis Research (FSR)announces the launch of the FSR Global Sarcoidosis Clinic Alliance, a groundbreaking initiative that will have a worldwide impact on advancing sarcoidosis research and improving the lives of those with sarcoidosis through patient and clinician education, engagement, and support.

Key Points: 
  • CHICAGO, June 21, 2022 /PRNewswire/ -- Foundation for Sarcoidosis Research (FSR)announces the launch of the FSR Global Sarcoidosis Clinic Alliance, a groundbreaking initiative that will have a worldwide impact on advancing sarcoidosis research and improving the lives of those with sarcoidosis through patient and clinician education, engagement, and support.
  • The FSR Global Sarcoidosis Clinic Alliance brings together sarcoidosis clinics and hospitals committed to finding a cure and offering evidence-based, patient-centric care for those living with sarcoidosis.
  • "We are honored to already be collaborating with 22 esteemed founding members of this groundbreaking rare disease initiative which will lead to extraordinary results.
  • Established in 2000, Foundation for Sarcoidosis Research (FSR), is the leading international non-profit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients through research, education, and support.

Torch Secures $40 Million in Series C Funding to Expand People Development Product Capabilities

Retrieved on: 
Monday, May 23, 2022
People, Glassdoor, Mentorship, Lead, Leadership, Norwest Venture Partners, Glint, Zynga, Solution, Virtus Investment Partners, SAN, Board, Board of directors, Growth, CEO, GLOBE, Video game, Management, Tutoring, Initialized Capital, Zendesk, Reddit, Chan Zuckerberg Initiative, Torch

This additional funding will help us meet accelerating market demand by expanding our product capabilities, ensuring strong partnerships with our customers, and scaling our operations."

Key Points: 
  • This additional funding will help us meet accelerating market demand by expanding our product capabilities, ensuring strong partnerships with our customers, and scaling our operations."
  • Since raising its $25 million Series B just last year, Torch has more than doubled its revenue and employee count year-on-year.
  • As the company has scaled, Torch has continued to innovate and expand its product features to create a holistic people development platform, including through its merger with Everwise which added mentoring and an extensive mentor network to the platforms learning and development product capabilities.
  • Leading brands like Zendesk and Reddit use Torch to develop their employees, create stronger leaders, and improve business results.

TileDB Secures investment From Verizon Ventures

Retrieved on: 
Tuesday, May 17, 2022
Data Management, Technology, Telecommunications, Mobile, Wireless, Software, Networks, Internet, Cloud, Nexus, CZI, Data science, Traction, IOT, TCO, Investment, Language, View, Array, MIT, Verizon Communications, Chan Zuckerberg Initiative, Industry, Weather, NanoString Technologies, Genetic distance, Rady, Venture, Intel Capital, Ecosystem, SQL, Data management, CEO, Network equipment, Computer data storage, Science, Biostatistics

TileDB, Inc. , a pioneering database company, announced today that it has received a strategic investment from Verizon Ventures , joining recent investments from Lockheed Martin Ventures, AMGEN Ventures and NTT Docomo Ventures.

Key Points: 
  • TileDB, Inc. , a pioneering database company, announced today that it has received a strategic investment from Verizon Ventures , joining recent investments from Lockheed Martin Ventures, AMGEN Ventures and NTT Docomo Ventures.
  • "At TileDB, we set out to debunk the myth around performance optimization in purpose-built data solutions," said Stavros Papadopoulos, TileDB Founder and CEO.
  • TileDBs platform helps solve these needs, said Kristina Serafim, Managing Director at Verizon Ventures.
  • TileDB, Inc. was spun out of MIT and Intel Labs in May 2017 and is backed by Two Bear Capital, Nexus Venture Partners, Uncorrelated Ventures, Intel Capital and Big Pi.